Lorcaserin
COMMON & BRAND NAMES
Belviq, Lorquess
EFFECTS CLASSIFICATION
Anorectic; Potential Hallucinogen
CHEMICAL NAME
(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
DESCRIPTION
Lorcaserin (Belviq) is a new serotonergic anorectic approved by the FDA as a weight-loss drug in June 2012. According to the FDA, it also has "CNS hallucinogenic properties". It was placed in Schedule IV on May 7, 2013. It is expected to become commercially available in June, 2013.
GENERAL INFORMATION #
EXPERIENCES #
Psychedelic Bodyamphetamine, by psychonaut4science
Submit a Report to our Experience Vaults
OFF-SITE RESOURCES
PRIMARY RESOURCES #
DEA Proposes Controlling Lorcaserin in Schedule IV - FDA Law Blog, Dec 20 2012
MEDIA COVERAGE #
Publication in Federal Register Tomorrow Moves BELVIQ Closer To Launch - The Wall Street Journal, May 7 2013
ARTICLES & WRITINGS #
FDA/DEA approved: lorcaserin, a diet drug with psychedelic effects at high doses - PsychedelicFrontier - May 9, 2013
RESEARCH & JOURNAL ARTICLES #